Corporate Finance and Capital Markets

Key Contacts

Thomas J. Friedmann

Partner Boston +1 617 728 7120

David S. Rosenthal

Partner New York +1 212 698 3616

A leading law firm for financial transactions in the global capital markets

Dechert’s corporate finance and capital markets group structures and executes complex, market-leading financial transactions for clients across today’s major industries and in countries and regions around the world. Our more than 125 lawyers, located in the firm’s U.S., European, Asian and Middle Eastern offices, collaborate with each other and other practice teams to execute domestic and cross-border transactions efficiently and seamlessly.

Dechert lawyers represent corporate and sovereign issuers, underwriters, financial sponsors, investors and selling shareholders in all types of public and private debt, equity, equity-linked and other securities offerings. We advise on U.S. and international listings, including on the New York Stock Exchange, NASDAQ Stock Market,London Stock Exchange, Hong Kong Stock Exchange, Euronext Amsterdam, Euronext Paris, Singapore Stock Exchange, Warsaw Stock Exchange and other global and regional exchanges.

In the emerging markets, Dechert has advised on innovative transactions by governments, banks and multinational corporations, in cluding in the Middle East and North Africa (MENA) region, Mediterranean Basin, Commonwealth of Independent States (CIS) region, Central and Eastern Europe and China. The firm is particularly strong in raising permanent capital, representing private equity firms and portfolio companies on IPO exits and debt financings, and in the life sciences industry for cross-border and domestic IPOs and other equity and debt offerings. The firm is also a leader in representing sovereign issuers and other market participants in sovereign bond offerings.

Dechert is widely recognized for having one of the leading international corporate finance and capital markets practices. (“ranked among the top issuer legal advisers for US equity Bloomberg offerings” 2016), (“Dechert’s capital markets practice is ‘outstanding in every way” The Legal 5002017), (“ranked among the top law firms in the United States and the United Kingdom IFLR 1000for capital markets” 2017), among other league tables and industry sources, have reported on the practice’s achievements.

Dechert’s team represents leading companies, governments and investment banks and financial sponsors in the full range of capital raising transactions:

Initial public offerings (IPOs)Share flotations, secondary and follow-on offeringsShelf offeringsPrivate placements under Rule 144A, Regulation S, Regulation D and Section 4(2) of the U.S. Securities Act of 1933Stand-alone Eurobonds and medium-term note programsLiability management transactions, including consent solicitations, exchange offers and tender offersPrivatizationsRestructuringsM&A-related securities transactions, including public transactions, going-private transactions, stock splits, rights offerings and exit financingsVenture capital transactionsRegistered direct offeringsConfidentially marketed public offeringsPrivate investments in public equity (PIPEs)Special purpose acquisition companies (SPACs)

Dechert’s team advises leading companies, governments and investment banks and financialsponsors on these products:

Common and preferred stockHigh-yield and investment grade debtConvertible and exchangeable securitiesEnhanced Income Securities (EIS)/Income Deposit Securities (IDS)American Depository Receipts (ADRs)Global Depository Receipts (GDRs)Eurobond offeringsEMTN programsCommercial paperStructured bonds

TRANSACTIONS

CORPORATE FINANCE PRODUCTS

PERMANENT CAPITAL VEHICLES

With Dechert’s financial services group, we structure and execute innovative approaches for capital raising transactions by permanent capital vehicles, including business development companies (BDCs), registered closed-end funds, listed European funds and specialty finance companies. The firm is a dominant legal adviser in this area.

As part of our market leading life sciences industry group, our capital markets lawyers advise on the full range of capital raising transactions on behalf of new and established life sciences companies. We work closely with these companies to capture and structure the capital they need to support the long development and commercialization process, ranging from early-stage venture financings and strategic equity investments to complex public offerings of equity and debt. We also advise the underwriters, including investment banks and other financial institutions, on life sciences industry financings.

Serving as outside counsel to many public companies, Dechert’s lawyers know the complex regulatory environment in which public companies and investment banks operate. Dechert advises on:

Regulatory and compliance matters under the U.S. Securities and Exchange Commission (SEC), U.S. stock exchanges and the Financial Industry Regulatory Authority (FINRA)Compliance matters under the FinancialConduct Authority (FCA) in the United Kingdom,the UK Listing Authority (UKLA) and the London Stock Exchange as well as the regulatory authorities in leading financial centers.Disclosure matters related to reporting obligations and securities offerings under the U.S. Securities Act of 1933 and the U.S. Securities Exchange Act of 1934Investment Company Act of 1940 and the Investment Advisers Act of 1940 matters for investment companies, advisers and broker-dealersCoordinating among the regulatory regimes in cross-border transactions

Our team, which includes many former SEC regulators, creates compliance programs and conduct smock inspections and examinations for regulated entities. We also help clients develop codes of ethics and policies and procedures for records management, insider tradingand other areas.

Related Professionals

LIFE SCIENCES

SECURITIES REGULATIONS AND COMPLIANCE

Related Practice Areas

Life Sciences

Permanent Capital

Regulatory Compliance

Visit our Risk Retention page

Learn More

View All Related Professionals

CAMILLE ABOUSLEIMAN

PartnerLondonT +44 20 7184 7400

JOHN E. ALESSI

AssociateBostonT +1 617 728 7186

GILES BELSEY

PartnerLondonT +44 20 7184 7353

DR. MARKUS P. BOLSINGER LL.M.

PartnerNew YorkT +1 212 698 3628MunichT +49 89 2121 6309

ROBERT BRADSHAW

PartnerLondonT +44 20 7184 7668

PIERRE-HENRI BRIEAU

AssociateParisT +33 1 57 57 80 03